Although NOS expression is associated with cancer progression and metastasis, recent studies have suggested that NOS3 may inhibit tumor growth, invasion, and angiogenesis, particularly in breast cancer, and CRC [11,12,13]. This evidence concerns the gene NOS3 and colorectal carcinoma.